Evidence map›Paper›PMID 1652768›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1991

The c-mos gene product is required for cyclin B accumulation during meiosis of mouse eggs.

S J O'Keefe, A A Kiessling, G M Cooper

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1991. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

S J O'KeefeDana-Farber Cancer Institute, Boston, MA.
A A Kiessling
G M Cooper

Funding

CHARACTERIZATION OF THE RET ONCOGENE AND ITS PRODUCTF32CA008224 · NCI · DANA-FARBER CANCER INSTITUTE · PI O'KEEFE, STEPHEN J.D · 1986 to 1989
–
PROTO-ONCOGENES IN GAMETOGENESIS AND EARLY DEVELOPMENTR01HD026594 · NICHD · DANA-FARBER CANCER INSTITUTE · PI COOPER, GEOFFREY M · 1989 to 1999
–
NCI NIH HHS CA08224NICHD NIH HHS HD26594
6 · The paper itself

Abstract

The c-mos protooncogene is expressed as a maternal message that is required for oocyte meiosis. The mechanism of action of c-mos was investigated by analysis of mouse eggs injected with antisense c-mos oligonucleotides. In antisense-injected eggs, maturation-promoting factor was not reactivated after the completion of meiosis I, leading to the formation of nuclei containing decondensed chromatin within 2-3 hr after polar body extrusion. This was correlated with a failure of the injected eggs to accumulate newly synthesized cyclin B. The c-mos protooncogene thus appears to affect the pathway that regulates cyclin B stability during meiosis of mouse eggs.

Indexed as

MeiosisProto-OncogenesAnimalsCells, CulturedCyclinsFemaleKineticsMiceMice, Inbred StrainsOocytesProtamine KinaseProtein-Tyrosine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-mosCyclinsProtamine KinaseProtein-Tyrosine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-mos

Identifiers

PMID1652768
PMCPMC52405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.